Refine
Year of publication
Document Type
- Article (58)
- Postprint (22)
- Other (8)
- Conference Proceeding (4)
- Review (3)
Language
- English (95) (remove)
Is part of the Bibliography
- yes (95)
Keywords
- Cardiac rehabilitation (19)
- cardiac rehabilitation (11)
- TAVI (7)
- rehabilitation (6)
- Return to work (5)
- coronary artery disease (5)
- mortality (5)
- Frailty (4)
- Telerehabilitation (4)
- elderly (4)
- Aftercare (3)
- Exercise therapy (3)
- Home-based (3)
- Rehabilitation (3)
- Total hip replacement (3)
- Total knee replacement (3)
- acute coronary syndrome (3)
- chronic kidney disease (3)
- coronary bypass grafting (3)
- genetics (3)
- hypertension (3)
- patient education (3)
- telemedicine (3)
- Acute coronary syndrome (2)
- Cardiovascular diseases (2)
- Geriatric rehabilitation (2)
- Malnutrition (2)
- Metabolic syndrome (2)
- Mobile diagnostics (2)
- Mortality (2)
- Nordic walking (2)
- Nutrition (2)
- Older patients (2)
- Outcome measures (2)
- Physical activity (2)
- Prevention (2)
- Prognosis (2)
- Rural health (2)
- Test-retest (2)
- Treatment pathways (2)
- acute coronary event (2)
- aftercare (2)
- cardiology (2)
- cardiorespiratory fitness (2)
- clinical study (2)
- cognitive impairment (2)
- control rates (2)
- cytochrome P450 17A1 (Cyp17A1) (2)
- dyslipidemia (2)
- electrical muscle stimulation (2)
- emotional status (2)
- endomyocardial biopsy (2)
- exercise capacity (2)
- exercise intensity (2)
- exercise movement techniques (2)
- exercise tests (2)
- exercise therapy (2)
- frailty (2)
- frailty tool (2)
- functional capacity (2)
- gait (2)
- glomerular filtration rate (2)
- healthy lifestyle (2)
- heart (2)
- heart failure (2)
- home-based (2)
- hospital readmission (2)
- lipids (2)
- multivariate modelling (2)
- music (2)
- music therapy (2)
- myocarditis (2)
- negative expectation (2)
- occupational prognosis (2)
- older patients (2)
- outcome measures (2)
- physical activity (2)
- prediction (2)
- prevalence (2)
- primary prevention (2)
- quality management (2)
- registry (2)
- reliability (2)
- return to work (2)
- risk factor (2)
- sleep apnoea (2)
- sleep-disordered breathing (2)
- stroke rehabilitation (2)
- surgical aortic valve replacement (sAVR) (2)
- telerehabilitation (2)
- total hip replacement (2)
- total knee replacement (2)
- transcatheter aortic valve implantation (TAVI) (2)
- treadmill (2)
- walking (2)
- work capacity (2)
- Acute myocardial infarction (1)
- Adipose tissue (1)
- Agreement (1)
- Anxiety (1)
- Aortic valve (1)
- Arterial hypertension (1)
- Autotaxin (1)
- Cardiac rehabilitation Chronic heart failure (1)
- Cardiovascular disease (1)
- Cardiovascular rehabilitation (1)
- Cardiovascular risk factor (1)
- Cardiovascular risk factors (1)
- Chronic heart failure (CHF) (1)
- Clinical study (1)
- Composite outcome measure (1)
- Control rates (1)
- Coronary artery bypass grafting (1)
- Coronary disease (1)
- Decannulation (1)
- Depression (1)
- Diabetes (1)
- Dyslipidemia (1)
- Esophagus carcinoma (1)
- Exercise capacity (1)
- Exercise tests (1)
- Exocrine pancreas (1)
- Force plate (1)
- Genetics (1)
- Glomerular filtration rate (1)
- Health economics (1)
- Health promotion (1)
- Heart (1)
- Hepatic insulin resistance (1)
- Home telemonitoring (1)
- Hypercholesterolemia (1)
- Hypertension (1)
- ICER (1)
- Incremental Cost-Effectiveness Ratio (ICER) (1)
- Insulin signaling (1)
- LPA(3) receptor subtype (1)
- Left ventricular hypertrophy (1)
- Lipid profile (1)
- Long term management (1)
- LumiraDx INR Test (1)
- LumiraDx Platform (1)
- Lysophosphatidic acid (1)
- Markerless motion capture system (1)
- Mechanical ventilation (1)
- Melatonin receptor type 2 (1)
- Mild cognitive impairment (1)
- Mobility (1)
- Motivation (1)
- Multiple risk factor intervention (1)
- Observational (1)
- Octogenarians (1)
- Oral anticoagulation (1)
- Patient self-management (1)
- Postural control (1)
- Predictors (1)
- Prospective study (1)
- Quality of life (1)
- RCT (1)
- Randomized controlled trial (1)
- Rehabilitation success (1)
- Reproducibility (1)
- Risk factor (1)
- Secondary prevention (1)
- Smoking (1)
- Smoking cessation (1)
- Social medicine (1)
- Social work (1)
- Steatorrhea (1)
- Tamm-Horsfall protein (1)
- Telemedicine (1)
- Tracheostomy (1)
- Transcatheter Aortic Valve Implantation (1)
- Travel (1)
- Vitamin k-antagonists (1)
- acute coronary (1)
- aortic valve stenosis (1)
- blood pressure (1)
- cardiac rehabilitation delivery (1)
- cardiovascular complications (1)
- cardiovascular rehabilitation (1)
- cardioverter-defibrillator (1)
- disease severity (1)
- exercise (1)
- exercise stress test (1)
- exercise tolerance (1)
- exercise training (1)
- guidelines (1)
- health cost (1)
- inpatient cardiac rehabilitation (1)
- insufficiency (1)
- intake screening (1)
- international normalized ratio (1)
- kardiologische Rehabilitation (1)
- kidney function (1)
- koronare Herzkrankheit (1)
- korperliche Leistungsfahigkeit (1)
- multimodal cardiac rehabilitation (1)
- myocardial infarction (1)
- of life (1)
- oral anticoagulation (1)
- organ damage (1)
- pension insurance (1)
- phenprocoumon (1)
- point-of-care (1)
- predictors (1)
- prognosis (1)
- quality (1)
- quality of life (1)
- regression toward the mean (1)
- rehabilitation outcome (1)
- secondary prevention (1)
- strength training (1)
- surgery (1)
- syndrome (1)
- telemonitoring (1)
- therapy volume (1)
- training and decision support system (1)
- vitamin K antagonist therapy (1)
Institute
- Department Sport- und Gesundheitswissenschaften (40)
- Strukturbereich Kognitionswissenschaften (23)
- Humanwissenschaftliche Fakultät (13)
- Fakultät für Gesundheitswissenschaften (5)
- Department Psychologie (2)
- Extern (2)
- Hochschulambulanz (2)
- Institut für Biochemie und Biologie (2)
- Institut für Ernährungswissenschaft (2)
- Gesundheitsmanagement (1)
Multicomponent cardiac rehabilitation in patients after transcatheter aortic valve implantation
(2017)
Background: In the last decade, transcatheter aortic valve implantation has become a promising treatment modality for patients with aortic stenosis and a high surgical risk. Little is known about influencing factors of function and quality of life during multicomponent cardiac rehabilitation. Methods: From October 2013 to July 2015, patients with elective transcatheter aortic valve implantation and a subsequent inpatient cardiac rehabilitation were enrolled in the prospective cohort multicentre study. Frailty-Index (including cognition, nutrition, autonomy and mobility), Short Form-12 (SF-12), six-minute walk distance (6MWD) and maximum work load in bicycle ergometry were performed at admission and discharge of cardiac rehabilitation. The relation between patient characteristics and improvements in 6MWD, maximum work load or SF-12 scales were studied univariately and multivariately using regression models. Results: One hundred and thirty-six patients (80.6 +/- 5.0 years, 47.8% male) were enrolled. 6MWD and maximum work load increased by 56.3 +/- 65.3 m (p < 0.001) and 8.0 +/- 14.9 watts (p < 0.001), respectively. An improvement in SF-12 (physical 2.5 +/- 8.7, p = 0.001, mental 3.4 +/- 10.2, p = 0.003) could be observed. In multivariate analysis, age and higher education were significantly associated with a reduced 6MWD, whereas cognition and obesity showed a positive predictive value. Higher cognition, nutrition and autonomy positively influenced the physical scale of SF-12. Additionally, the baseline values of SF-12 had an inverse impact on the change during cardiac rehabilitation. Conclusions: Cardiac rehabilitation can improve functional capacity as well as quality of life and reduce frailty in patients after transcatheter aortic valve implantation. An individually tailored therapy with special consideration of cognition and nutrition is needed to maintain autonomy and empower octogenarians in coping with challenges of everyday life.
Background: Evidence that home telemonitoring (HTM) for patients with chronic heart failure (CHF) offers clinical benefit over usual care is controversial as is evidence of a health economic advantage. Therefore the CardioBBEAT trial was designed to prospectively assess the health economic impact of a dedicated home monitoring system for patients with CHF based on actual costs directly obtained from patients’ health care providers.
Methods: Between January 2010 and June 2013, 621 patients (mean age 63,0 ± 11,5 years, 88 % male) with a confirmed diagnosis of CHF (LVEF ≤ 40 %) were enrolled and randomly assigned to two study groups comprising usual care with and without an interactive bi-directional HTM (Motiva®). The primary endpoint was the Incremental Cost-Effectiveness Ratio (ICER) established by the groups’ difference in total cost and in the combined clinical endpoint “days alive and not in hospital nor inpatient care per potential days in study” within the follow up of 12 months. Secondary outcome measures were total mortality and health related quality of life (SF-36, WHO-5 and KCCQ).
Results: In the intention-to-treat analysis, total mortality (HR 0.81; 95% CI 0.45 – 1.45) and days alive and not in hospital (343.3 ± 55.4 vs. 347.2 ± 43.9; p = 0.909) were not significantly different between HTM and usual care. While the resulting primary endpoint ICER was not positive (-181.9; 95% CI −1626.2 ± 1628.9), quality of life assessed by SF-36, WHO-5 and KCCQ as a secondary endpoint was significantly higher in the HTW group at 6 and 12 months of follow-up.
Conclusions: The first simultaneous assessment of clinical and economic outcome of HTM in patients with CHF did not demonstrate superior incremental cost effectiveness compared to usual care. On the other hand, quality of life was improved. It remains open whether the tested HTM solution represents a useful innovative approach in the recent health care setting.
Frailty assessment is recommended before elective transcatheter aortic valve implantation (TAVI) to determine post-interventional prognosis. Several studies have investigated frailty in TAVI-patients using numerous assessments; however, it remains unclear which is the most appropriate tool for clinical practice. Therefore, we evaluate which frailty assessment is mainly used and meaningful for ≤30-day and ≥1-year prognosis in TAVI patients. Randomized controlled or observational studies (prospective/retrospective) investigating all-cause mortality in older (≥70 years) TAVI patients were identified (PubMed; May 2020). In total, 79 studies investigating frailty with 49 different assessments were included. As single markers of frailty, mostly gait speed (23 studies) and serum albumin (16 studies) were used. Higher risk of 1-year mortality was predicted by slower gait speed (highest Hazard Ratios (HR): 14.71; 95% confidence interval (CI) 6.50–33.30) and lower serum albumin level (highest HR: 3.12; 95% CI 1.80–5.42). Composite indices (five items; seven studies) were associated with 30-day (highest Odds Ratio (OR): 15.30; 95% CI 2.71–86.10) and 1-year mortality (highest OR: 2.75; 95% CI 1.55–4.87). In conclusion, single markers of frailty, in particular gait speed, were widely used to predict 1-year mortality. Composite indices were appropriate, as well as a comprehensive assessment of frailty. View Full-Text
Frailty assessment is recommended before elective transcatheter aortic valve implantation (TAVI) to determine post-interventional prognosis. Several studies have investigated frailty in TAVI-patients using numerous assessments; however, it remains unclear which is the most appropriate tool for clinical practice. Therefore, we evaluate which frailty assessment is mainly used and meaningful for ≤30-day and ≥1-year prognosis in TAVI patients. Randomized controlled or observational studies (prospective/retrospective) investigating all-cause mortality in older (≥70 years) TAVI patients were identified (PubMed; May 2020). In total, 79 studies investigating frailty with 49 different assessments were included. As single markers of frailty, mostly gait speed (23 studies) and serum albumin (16 studies) were used. Higher risk of 1-year mortality was predicted by slower gait speed (highest Hazard Ratios (HR): 14.71; 95% confidence interval (CI) 6.50–33.30) and lower serum albumin level (highest HR: 3.12; 95% CI 1.80–5.42). Composite indices (five items; seven studies) were associated with 30-day (highest Odds Ratio (OR): 15.30; 95% CI 2.71–86.10) and 1-year mortality (highest OR: 2.75; 95% CI 1.55–4.87). In conclusion, single markers of frailty, in particular gait speed, were widely used to predict 1-year mortality. Composite indices were appropriate, as well as a comprehensive assessment of frailty. View Full-Text
Electrical muscle stimulation (EMS) is an increasingly popular training method and has become the focus of research in recent years. New EMS devices offer a wide range of mobile applications for whole-body EMS (WB-EMS) training, e.g., the intensification of dynamic low-intensity endurance exercises through WB-EMS. The present study aimed to determine the differences in exercise intensity between WB-EMS-superimposed and conventional walking (EMS-CW), and CON and WB-EMS-superimposed Nordic walking (WB-EMS-NW) during a treadmill test. Eleven participants (52.0 ± years; 85.9 ± 7.4 kg, 182 ± 6 cm, BMI 25.9 ± 2.2 kg/m2) performed a 10 min treadmill test at a given velocity (6.5 km/h) in four different test situations, walking (W) and Nordic walking (NW) in both conventional and WB-EMS superimposed. Oxygen uptake in absolute (VO2) and relative to body weight (rel. VO2), lactate, and the rate of perceived exertion (RPE) were measured before and after the test. WB-EMS intensity was adjusted individually according to the feedback of the participant. The descriptive statistics were given in mean ± SD. For the statistical analyses, one-factorial ANOVA for repeated measures and two-factorial ANOVA [factors include EMS, W/NW, and factor combination (EMS*W/NW)] were performed (α = 0.05). Significant effects were found for EMS and W/NW factors for the outcome variables VO2 (EMS: p = 0.006, r = 0.736; W/NW: p < 0.001, r = 0.870), relative VO2 (EMS: p < 0.001, r = 0.850; W/NW: p < 0.001, r = 0.937), and lactate (EMS: p = 0.003, r = 0.771; w/NW: p = 0.003, r = 0.764) and both the factors produced higher results. However, the difference in VO2 and relative VO2 is within the range of biological variability of ± 12%. The factor combination EMS*W/NW is statistically non-significant for all three variables. WB-EMS resulted in the higher RPE values (p = 0.035, r = 0.613), RPE differences for W/NW and EMS*W/NW were not significant. The current study results indicate that WB-EMS influences the parameters of exercise intensity. The impact on exercise intensity and the clinical relevance of WB-EMS-superimposed walking (WB-EMS-W) exercise is questionable because of the marginal differences in the outcome variables.
Electrical muscle stimulation (EMS) is an increasingly popular training method and has become the focus of research in recent years. New EMS devices offer a wide range of mobile applications for whole-body EMS (WB-EMS) training, e.g., the intensification of dynamic low-intensity endurance exercises through WB-EMS. The present study aimed to determine the differences in exercise intensity between WB-EMS-superimposed and conventional walking (EMS-CW), and CON and WB-EMS-superimposed Nordic walking (WB-EMS-NW) during a treadmill test. Eleven participants (52.0 ± years; 85.9 ± 7.4 kg, 182 ± 6 cm, BMI 25.9 ± 2.2 kg/m2) performed a 10 min treadmill test at a given velocity (6.5 km/h) in four different test situations, walking (W) and Nordic walking (NW) in both conventional and WB-EMS superimposed. Oxygen uptake in absolute (VO2) and relative to body weight (rel. VO2), lactate, and the rate of perceived exertion (RPE) were measured before and after the test. WB-EMS intensity was adjusted individually according to the feedback of the participant. The descriptive statistics were given in mean ± SD. For the statistical analyses, one-factorial ANOVA for repeated measures and two-factorial ANOVA [factors include EMS, W/NW, and factor combination (EMS*W/NW)] were performed (α = 0.05). Significant effects were found for EMS and W/NW factors for the outcome variables VO2 (EMS: p = 0.006, r = 0.736; W/NW: p < 0.001, r = 0.870), relative VO2 (EMS: p < 0.001, r = 0.850; W/NW: p < 0.001, r = 0.937), and lactate (EMS: p = 0.003, r = 0.771; w/NW: p = 0.003, r = 0.764) and both the factors produced higher results. However, the difference in VO2 and relative VO2 is within the range of biological variability of ± 12%. The factor combination EMS*W/NW is statistically non-significant for all three variables. WB-EMS resulted in the higher RPE values (p = 0.035, r = 0.613), RPE differences for W/NW and EMS*W/NW were not significant. The current study results indicate that WB-EMS influences the parameters of exercise intensity. The impact on exercise intensity and the clinical relevance of WB-EMS-superimposed walking (WB-EMS-W) exercise is questionable because of the marginal differences in the outcome variables.
Background
The metabolic syndrome (MetS) is a risk cluster for a number of secondary diseases. The implementation of prevention programs requires early detection of individuals at risk. However, access to health care providers is limited in structurally weak regions. Brandenburg, a rural federal state in Germany, has an especially high MetS prevalence and disease burden. This study aims to validate and test the feasibility of a setup for mobile diagnostics of MetS and its secondary diseases, to evaluate the MetS prevalence and its association with moderating factors in Brandenburg and to identify new ways of early prevention, while establishing a “Mobile Brandenburg Cohort” to reveal new causes and risk factors for MetS.
Methods
In a pilot study, setups for mobile diagnostics of MetS and secondary diseases will be developed and validated. A van will be equipped as an examination room using point-of-care blood analyzers and by mobilizing standard methods. In study part A, these mobile diagnostic units will be placed at different locations in Brandenburg to locally recruit 5000 participants aged 40-70 years. They will be examined for MetS and advice on nutrition and physical activity will be provided. Questionnaires will be used to evaluate sociodemographics, stress perception, and physical activity. In study part B, participants with MetS, but without known secondary diseases, will receive a detailed mobile medical examination, including MetS diagnostics, medical history, clinical examinations, and instrumental diagnostics for internal, cardiovascular, musculoskeletal, and cognitive disorders. Participants will receive advice on nutrition and an exercise program will be demonstrated on site. People unable to participate in these mobile examinations will be interviewed by telephone. If necessary, participants will be referred to general practitioners for further diagnosis.
Discussion
The mobile diagnostics approach enables early detection of individuals at risk, and their targeted referral to local health care providers. Evaluation of the MetS prevalence, its relation to risk-increasing factors, and the “Mobile Brandenburg Cohort” create a unique database for further longitudinal studies on the implementation of home-based prevention programs to reduce mortality, especially in rural regions.
Trial registration
German Clinical Trials Register, DRKS00022764; registered 07 October 2020—retrospectively registered.
Background
The metabolic syndrome (MetS) is a risk cluster for a number of secondary diseases. The implementation of prevention programs requires early detection of individuals at risk. However, access to health care providers is limited in structurally weak regions. Brandenburg, a rural federal state in Germany, has an especially high MetS prevalence and disease burden. This study aims to validate and test the feasibility of a setup for mobile diagnostics of MetS and its secondary diseases, to evaluate the MetS prevalence and its association with moderating factors in Brandenburg and to identify new ways of early prevention, while establishing a “Mobile Brandenburg Cohort” to reveal new causes and risk factors for MetS.
Methods
In a pilot study, setups for mobile diagnostics of MetS and secondary diseases will be developed and validated. A van will be equipped as an examination room using point-of-care blood analyzers and by mobilizing standard methods. In study part A, these mobile diagnostic units will be placed at different locations in Brandenburg to locally recruit 5000 participants aged 40-70 years. They will be examined for MetS and advice on nutrition and physical activity will be provided. Questionnaires will be used to evaluate sociodemographics, stress perception, and physical activity. In study part B, participants with MetS, but without known secondary diseases, will receive a detailed mobile medical examination, including MetS diagnostics, medical history, clinical examinations, and instrumental diagnostics for internal, cardiovascular, musculoskeletal, and cognitive disorders. Participants will receive advice on nutrition and an exercise program will be demonstrated on site. People unable to participate in these mobile examinations will be interviewed by telephone. If necessary, participants will be referred to general practitioners for further diagnosis.
Discussion
The mobile diagnostics approach enables early detection of individuals at risk, and their targeted referral to local health care providers. Evaluation of the MetS prevalence, its relation to risk-increasing factors, and the “Mobile Brandenburg Cohort” create a unique database for further longitudinal studies on the implementation of home-based prevention programs to reduce mortality, especially in rural regions.
Trial registration
German Clinical Trials Register, DRKS00022764; registered 07 October 2020—retrospectively registered.
After surgical treatment of cancer of the esophagus or the esophagogastric junction we observed steatorrhea, which is so far seldom reported. We analyzed all patients treated in our rehabilitation clinic between 2011 and 2014 and focused on the impact of surgery on digestion of fat. Reported steatorrhea was anamnestic, no pancreatic function test was made. Here we show the results from 51 patients. Twenty-three (45%) of the patients reported steatorrhea. Assuming decreased pancreatic function pancreatic enzyme replacement therapy (PERT) was started or modified during the rehabilitation stay (in the following called STEA(+)). These patients were compared with the patients without steatorrhea and without PERT (STEA(-)). Maximum weight loss between surgery and rehabilitation start was 18 kg in STEA(+) patient and 15.3 kg in STEA(-) patients. STEA(+) patients gained more weight under PERT during the rehabilitation phase (3 wk) than STEA(-) patients without PERT (+1.0 kg vs. -0.3 kg, P = 0.032). We report for the first time, that patients after cancer related esophageal surgery show anamnestic signs of exocrine pancreas insufficiency and need PERT to gain body weight.